IxCell hUC-MSC-O

human umbilical cord-derived mesenchymal stem cell product · Shanghai IxCell Biotechnology Co., LTD

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IxCell hUC-MSC-O, covering 2024-12-06 to 2024-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of IxCell hUC-MSC-O in Patients With Knee Osteoarthritis [Phase 3]